PTT 001
Alternative Names: PTT-001Latest Information Update: 10 Mar 2024
At a glance
- Originator Pyrotech Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Pyroptosis modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cancer
Most Recent Events
- 20 Feb 2024 Phase-I clinical trials in Cancer (unspecified route)